Clinical Nutrition Market Size, Growth, Industry Report 2033

The global clinical nutrition market reached USD 55.8 billion in 2024 and is forecast to surge to USD 104.6 billion by 2033, growing at a CAGR of 7.2%. This growth is fuelled by rising chronic disease prevalence, technological breakthroughs in personalized and medical nutrition, ageing demographics, and changing dietary habits - all of which are promoting awareness and demand for clinical nutrition solutions.

STUDY ASSUMPTION YEARS

• BASE YEAR: 2024
• HISTORICAL YEAR: 2019–2024
• FORECAST YEAR: 2025–2033

CLINICAL NUTRITION MARKET KEY TAKEAWAYS

• Asia‑Pacific holds the largest regional market share, supported by rising chronic disease burden and expanding healthcare access.
• Infant nutrition remains the top product segment, fulfilling early developmental dietary needs.
• Oral administration leads the route segment due to convenience, safety, and broad acceptance.
• Application-wise, cancer-related nutrition support and malnutrition interventions are fuelling adoption.
• Pediatric end-users dominate demand, driven by high child populations and targeted nutritional formulations.
• Market growth: from USD 55.8 B in 2024 to USD 104.6 B by 2033, at 7.2% CAGR.

MARKET GROWTH FACTORS

 1. Clinical Nutrition's Future: How Technology Is Helping Customised Diet?

Clinical nutrition is undergoing a remarkable transformation, fueled by advancements in nutrigenomics, metabolomics, wearable technology, and digital health platforms. These breakthroughs give us the ability to precisely evaluate how our metabolism and genetics respond, opening the door to personalized nutrition plans that improve therapy outcomes and support patient commitment. By leveraging apps and smart gadgets, people can take an active role in managing their health with customized dietary suggestions and live tracking. This personalized strategy is generating a lot of buzz in both clinical and homecare environments.

2. Why Is the Clinical Nutrition Market Growing Due to an Ageing Global Population?

The rapid growth of the aging population around the world, especially in the Asia-Pacific region, is creating a strong demand for clinical nutrition solutions. As the number of elderly individuals increases, we’re also noticing a rise in age-related nutritional deficiencies and chronic conditions like diabetes, heart disease, and cancer. These health challenges are driving the need for specialized nutritional therapies. With projections suggesting that the number of people aged 80 and older will triple by 2050, there’s an increasing focus on personalized nutrition to enhance immune health, maintain muscle mass, and support metabolic function.

3. Evidence-Based Nutritional Testing's Rise Among Health Professionals: From Lab to Clinic

Healthcare professionals and consumers are becoming more aware of the crucial role nutrition plays in preventive healthcare. This growing recognition is driving the integration of evidence-based screening and dietary counseling into everyday practices, which in turn is fueling a rising demand for functional foods, fortified beverages, and ready-to-drink (RTD) nutritional supplements. Thanks to various public health initiatives, educational campaigns, and supportive health policies, this focus on early nutritional intervention is significantly boosting growth opportunities in the clinical nutrition market.

Request for a sample copy of this report: 

https://www.imarcgroup.com/clinical-nutrition-market/requestsample

MARKET SEGMENTATION

Breakup by Product:

• Infant Nutrition: addresses dietary needs of newborns with formula and supplements
• Parental Nutrition
• Enteral Nutrition

Breakup by Route of Administration:

• Oral
• Enteral
• Parenteral

Breakup by Application:

• Cancer
• Malnutrition
• Metabolic Disorders
• Gastrointestinal Disorders
• Neurological Disorders
• Others

Breakup by End User:

• Pediatric
• Adults
• Geriatric

Breakup by Region:

• North America (United States, Canada)
• Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa

REGIONAL INSIGHTS

Asia‑Pacific leads the clinical nutrition market, propelled by rapid urbanization, rising chronic disease incidence, and expanding geriatric populations in India and China. With improving healthcare access and higher disposable incomes, demand for specialized nutrition and preventive therapy continues to grow strongly.

RECENT DEVELOPMENTS & NEWS

Recent innovations include Nestlé Health Science’s 2023 partnership with EraCal Therapeutics to develop new nutraceuticals targeting metabolic diseases, reflecting a shift toward functional, health-focused foods. Danone’s May 2024 acquisition of U.S. tube‑feeding specialist Functional Formularies has bolstered its enteral nutrition portfolio and U.S. presence. Friesland Campina Ingredients released Nutri Whey™ ProHeat, a heat-stable whey protein for medical nutrition, showcasing cutting-edge ingredient innovation.

KEY PLAYERS

Abbott Laboratories, B. Braun Melsungen AG, BASF SE, Baxter International Inc., Danone S.A., Fresenius SE & Co. KGaA, Grifols S.A., Koninklijke DSM N.V., Meiji Holdings Co. Ltd., Nestlé S.A., Perrigo Company plc, Reckitt Benckiser Group PLC, etc.

Ask Analyst for Customization: 

https://www.imarcgroup.com/request?type=report&id=5995&flag=C

Mainframe Market: https://www.imarcgroup.com/mainframe-market

Transthyretin Amyloidosis Treatment Market: https://www.imarcgroup.com/transthyretin-amyloidosis-treatment-market

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as part of the customization.

About Us:

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provides a comprehensive suite of market entry and expansion services. IMARC offerings include a thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape, benchmarking analyses, pricing and cost research, and procurement research.

Contact Us:

IMARC Group

134 N 4th St., Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel No:(D) +91 120 433 0800

United States: (+1-201971-6302)